The second patient who had received in August at Nantes University Hospital CARMAT artificial heart died Saturday after a problem with the operation of this prosthesis, said Monday in a statement. This 69 year old man was hospitalized Friday in Nantes because of a “circulatory failure,” the group said. “The surgical team has been a drift functional the prosthesis, the patient was put under cardiopulmonary support in intensive care,” said CARMAT, adding that it had been decided on Saturday to implant a new CARMAT prosthesis. “The operation was brought to completion and blood flow has been restored,” the group. “Despite the efforts made, postoperative complications multisystem settled, and the patient died Saturday, May 2 at the end of the afternoon.” The company states that the analyzes are in progress on the prosthesis to identify possible causes of death. “We join pain close to the patient and wish to pay tribute to the latter who lived nearly nine months with his heart prosthesis leading an almost normal life with his family, “written in the press Marcello Conviti, CEO of CARMAT. “This event is to be situated in the context of the feasibility test phase of an extremely innovative device for patients with end-stage heart failure. The company remains firmly confident in the ability of the prosthesis and renews the total commitment of teams in this sense, “he added. Claude Dany, 76, the first patient implanted in Paris in December 2013, had died 74 days after placement of the prosthesis. Professor Daniel Duveau Nantes, which had operated the second patient in Nantes in August, had assured last month that it was “very good”. A third patient was successfully implanted, 8 April in Paris with an artificial bio CARMAT heart to replace permanently a failing heart.
Test phase
Monday, May 4, 2015
The second patient with CARMAT heart is deceased – Le Point
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment